<DOC>
	<DOCNO>NCT02933879</DOCNO>
	<brief_summary>A Randomized , Placebo-Controlled , Double-Blind , Parallel-Group , Multi- Site Phase 2b Clinical Study Assess Efficacy , Safety Tolerability 8-Week Regimens NVXT topical product Patients Mild Moderate Onychomycosis</brief_summary>
	<brief_title>Randomized , Placebo-Controlled , Double-Blind , Parallel-Group , Multi-Site Phase 2b Clinical Study</brief_title>
	<detailed_description>Evaluate safety tolerability two regimen NVXT ( Treatment Groups A B ) patient mild moderate distal subungual onychomycosis target toenail .</detailed_description>
	<mesh_term>Onychomycosis</mesh_term>
	<criteria>Clinical diagnosis onychomycosis target toenail ( defined one infect great toenail ) . Females pregnant , lactate likely become pregnant study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>